biosimilars

Mylan, Fujifilm score EU thumbs-up for Humira biosimilar, putting more pressure on AbbVie
Mylan, Fujifilm score EU thumbs-up for Humira biosimilar, putting more pressure on AbbVie
Forbes
AbbVie
Mylan Labs
Fujifilm
biosimilars
Humira
Flag link:
Senate passes 'pay-for-delay' bill for biosimilars
Senate passes 'pay-for-delay' bill for biosimilars
BioCentury
biosimilars
pay-for-delay
Flag link:
Mylan biosimilar to stress test Amgen Neulasta franchise, analyst predicts
Mylan biosimilar to stress test Amgen Neulasta franchise, analyst predicts
Biopharma Dive
Amgen
Neulasta
biosimilars
Flag link:
Preparing for the incoming wave of biosimilars in oncology
Preparing for the incoming wave of biosimilars in oncology
ESMO Open
biosimilars
oncology
cancer
Flag link:
Amgen, Sandoz begin biosimilar trial with top-selling Enbrel at stake
Amgen, Sandoz begin biosimilar trial with top-selling Enbrel at stake
Biopharma Dive
Amgen
Sandoz
Enbrel
biosimilars
Novartis
Flag link:
FDA panel to discuss Celltrion biosimilar
FDA panel to discuss Celltrion biosimilar
BioCentury
FDA
Rituxan/MabThera
biosimilars
CT-P10
Celltrion
Flag link:
Companies Discuss Biosimilars, Suggest Reforms at FDA Public Meeting
Companies Discuss Biosimilars, Suggest Reforms at FDA Public Meeting
RAPS.org
FDA
biosimilars
Flag link:
AbbVie braces for impact of Humira biosimilars in Europe
AbbVie braces for impact of Humira biosimilars in Europe
Pharmaforum
AbbVie
Humira
Europe
biosimilars
Flag link:
Pfizer Calls for FDA Guidance to Address False and Misleading Biosimilar Ads
Pfizer Calls for FDA Guidance to Address False and Misleading Biosimilar Ads
RAPS.org
Pfizer
FDA
biosimilars
Amgen
Genentech
drug ads
Flag link:
Pfizer lawsuit could clear path for biosimilars
Pfizer lawsuit could clear path for biosimilars
Medical Marketing and Media
Pfizer
JNJ
Remicade
biosimilars
Inflectra
Flag link:
Insurers, CVS Call on FDA to Finalize Interchangeable Biosimilar Guidance
Insurers, CVS Call on FDA to Finalize Interchangeable Biosimilar Guidance
RAPS.org
FDA
biosimilars
insurers
CVS Health
Flag link:
Biosimilars and Complex Generics Uptake Not as Expected – Why is that a Surprise?
Biosimilars and Complex Generics Uptake Not as Expected – Why is that a Surprise?
Lachman Consultants
biosimilars
Hatch Waxman Act
generics
Flag link:
Judge Denies J&J Motion to Dismiss Pfizer Lawsuit Over Remicade
Judge Denies J&J Motion to Dismiss Pfizer Lawsuit Over Remicade
RAPS.org
Pfizer
JNJ
Remicade
biosimilars
Inflectra
Flag link:
Clover Initiates Ph I Study of Enbrel Biosimilar in China
Clover Initiates Ph I Study of Enbrel Biosimilar in China
CP Wire
Clover BioPharmaceuticals
Enbrel
Amgen
biosimilars
SCB-808
China
Flag link:
Pfizer Receives European Approval for Herceptin Biosimilar, Trazimera
Pfizer Receives European Approval for Herceptin Biosimilar, Trazimera
CP Wire
Ttrazimera
Pfizer
biosimilars
Herceptin
Europe
Roche
Flag link:
FDA Plans Hearing on Biosimilar Competition, Development
FDA Plans Hearing on Biosimilar Competition, Development
RAPS.org
FDA
biosimilars
competition
Flag link:
Pfizer gets FDA approval for drug similar to Amgen's Neupogen
Pfizer gets FDA approval for drug similar to Amgen's Neupogen
Marketwatch
Pfizer
FDA
biosimilars
Amgen
Neupogen
Nivestym
Flag link:
FDA’s Gottlieb slams drug makers for stalling release of biosimilars
FDA’s Gottlieb slams drug makers for stalling release of biosimilars
Stat
FDA
Scott Gottlieb
biosimilars
competition
Flag link:
Mylan signs U.S. license deal on Humira with AbbVie
Mylan signs U.S. license deal on Humira with AbbVie
Yahoo/Reuters
AbbVie
Mylan
biosimilars
Humira
Flag link:
Could Amgen soften the Neulasta biosimilar blow with an Alexion buy?
Could Amgen soften the Neulasta biosimilar blow with an Alexion buy?
Fierce Pharma
Amgen
biosimilars
Neulasta
Alexion
M&A
Flag link:

Pages